- Home
- JNJ vs ABT Comparison
JNJ vs ABT Comparison
Compare JNJ & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JNJ | ABT |
|---|---|---|
| Founded | 1886 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 505.3B | 222.8B |
| IPO Year | 1944 | N/A |
Fundamental Metrics
Financial Performance| Metric | JNJ | ABT |
|---|---|---|
| Price | $219.57 | $122.37 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 18 |
| Target Price | ★ $209.27 | $147.56 |
| AVG Volume (30 Days) | ★ 7.8M | 5.9M |
| Earning Date | 01-21-2026 | 01-22-2026 |
| Dividend Yield | ★ 2.37% | 2.04% |
| EPS Growth | 71.26 | ★ 141.97 |
| EPS | ★ 10.35 | 7.96 |
| Revenue | ★ $92,149,000,000.00 | $43,843,000,000.00 |
| Revenue This Year | $6.63 | $7.57 |
| Revenue Next Year | $5.49 | $7.96 |
| P/E Ratio | $21.22 | ★ $15.52 |
| Revenue Growth | 5.08 | ★ 6.37 |
| 52 Week Low | $141.50 | $110.86 |
| 52 Week High | $219.75 | $141.23 |
Technical Indicators
Market Signals| Indicator | JNJ | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 71.85 | 40.36 |
| Support Level | $203.85 | $122.20 |
| Resistance Level | $208.98 | $125.09 |
| Average True Range (ATR) | 3.39 | 2.11 |
| MACD | 1.24 | -0.23 |
| Stochastic Oscillator | 98.44 | 13.53 |
Price Performance
Historical ComparisonAbout JNJ Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.